27 August 2018: Robbie Turner, director of pharmacy and member experience at the Royal Pharmaceutical Society, spoke to the Daily Mail
about the shortage of adrenaline auto-injectors, such as the EpiPen.
“Even with pharmacists working flat out, it has become increasingly difficult to get hold of supplies of some adrenaline pens, and it is patients who suffer,” Turner said.
“This is a global problem and will require international solutions.”
Last updated